Table I.
Patient characteristics (n=55).
| Characteristics | Patient no. | Percentage |
|---|---|---|
| Gender | ||
| Male | 41 | 75 |
| Female | 14 | 25 |
| Age (years) | ||
| 14–20 | 6 | 10 |
| 21–60 | 41 | 75 |
| 60–80 | 8 | 15 |
| ECOG PS | ||
| 0 | 42 | 76 |
| 1 | 9 | 16 |
| 2 | 4 | 8 |
| B symptoms | ||
| Yes | 32 | 58 |
| No | 23 | 42 |
| Ann Arbor stage | ||
| I/II | 45 | 82 |
| III/IV | 10 | 18 |
| IPI | ||
| 1 | 29 | 53 |
| 2 | 16 | 29 |
| 3 | 8 | 15 |
| 4 | 2 | 3 |
| LDH level | ||
| Elevated | 12 | 22 |
| Normal | 43 | 78 |
| HPS | ||
| Yes | 10 | 18 |
| No | 45 | 82 |
| Involved sites | ||
| Nasal cavity/nasopharynx | 48 | 87 |
| Other | 7 | 13 |
ECOG PS, Eastern Cooperative Oncology Group performance status; IPI, international prognostic index; LDH, lactate dehydrogenase; HPS, hemophagocytic syndrome.